▲ Peaking
Business
With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Merck is initiating voluntary licensing agreements to broaden global access for its experimental monthly oral HIV prevention pill.
1 trends tracked about this subject — the full history, oldest to newest below.
Merck is initiating voluntary licensing agreements to broaden global access for its experimental monthly oral HIV prevention pill.